Fundies.
English

Segment disclosures

Company overview

ENDO HEALTH SOLUTIONS INC.

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

14 dimension combinations 157 retained observations 16 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Anatomical Pathology Services · Healthtronics

Reporting Unit · Statement Business Segments

Source dimensions endp:ReportingUnitAxis=endp:AnatomicalPathologyServicesMember;us-gaap:StatementBusinessSegmentsAxis=endp:HealthtronicsMember
PeriodValueUnitFiledEvidence
2013-07-01 – 2013-09-302500000 USD20131105Open filing evidence
2013-01-01 – 2013-09-3013600000 USD20131105Open filing evidence
2013-04-01 – 2013-06-305700000 USD20130806Open filing evidence
2013-01-01 – 2013-06-3011000000 USD20130806Open filing evidence
2012-07-01 – 2012-09-305200000 USD20131105Open filing evidence
2012-01-01 – 2012-09-3015200000 USD20131105Open filing evidence
2012-04-01 – 2012-06-306000000 USD20130806Open filing evidence
2012-01-01 – 2012-06-3010000000 USD20130806Open filing evidence

Ams

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=endp:AmsMember
PeriodValueUnitFiledEvidence
2013-01-01 – 2013-12-31492226000 USD20140303Open filing evidence
2013-07-01 – 2013-09-30111244000 USD20131105Open filing evidence
2013-01-01 – 2013-09-30359867000 USD20131105Open filing evidence
2013-04-01 – 2013-06-30125971000 USD20130806Open filing evidence
2013-01-01 – 2013-06-30248623000 USD20130806Open filing evidence
2013-01-01 – 2013-03-31122652000 USD20130507Open filing evidence
2012-01-01 – 2012-12-31504487000 USD20140303Open filing evidence
2012-07-01 – 2012-09-30113304000 USD20131105Open filing evidence
2012-01-01 – 2012-09-30371601000 USD20131105Open filing evidence
2012-04-01 – 2012-06-30128131000 USD20130806Open filing evidence
2012-01-01 – 2012-06-30258297000 USD20130806Open filing evidence
2012-01-01 – 2012-03-31130166000 USD20130507Open filing evidence
2011-01-01 – 2011-12-31300299000 USD20140303Open filing evidence
2011-07-01 – 2011-09-30131519000 USD20121105Open filing evidence
2011-01-01 – 2011-09-30158331000 USD20121105Open filing evidence
2011-04-01 – 2011-06-3026812000 USD20120807Open filing evidence
2011-01-01 – 2011-06-3026812000 USD20120807Open filing evidence
2010-01-01 – 2010-12-310 USD20130301Open filing evidence

Ams · US

Statement Business Segments · Statement Geographical

Source dimensions us-gaap:StatementBusinessSegmentsAxis=endp:AmsMember;us-gaap:StatementGeographicalAxis=country:US
PeriodValueUnitFiledEvidence
2013-01-01 – 2013-12-31315054000 USD20140303Open filing evidence
2013-07-01 – 2013-09-3075484000 USD20131105Open filing evidence
2013-01-01 – 2013-09-30233091000 USD20131105Open filing evidence
2013-04-01 – 2013-06-3079240000 USD20130806Open filing evidence
2013-01-01 – 2013-06-30157607000 USD20130806Open filing evidence
2013-01-01 – 2013-03-3178367000 USD20130507Open filing evidence
2012-01-01 – 2012-12-31330087000 USD20140303Open filing evidence
2012-07-01 – 2012-09-3075480000 USD20131105Open filing evidence
2012-01-01 – 2012-09-30246385000 USD20131105Open filing evidence
2012-04-01 – 2012-06-3083935000 USD20130806Open filing evidence
2012-01-01 – 2012-06-30170905000 USD20130806Open filing evidence
2012-01-01 – 2012-03-3186970000 USD20130507Open filing evidence
2011-01-01 – 2011-12-31202462000 USD20140303Open filing evidence
2011-07-01 – 2011-09-3091807000 USD20121105Open filing evidence
2011-01-01 – 2011-09-30107378000 USD20121105Open filing evidence
2011-04-01 – 2011-06-3015571000 USD20120807Open filing evidence
2011-01-01 – 2011-06-3015571000 USD20120807Open filing evidence
2010-01-01 – 2010-12-310 USD20130301Open filing evidence

Ams · International

Statement Business Segments · Statement Geographical

Source dimensions us-gaap:StatementBusinessSegmentsAxis=endp:AmsMember;us-gaap:StatementGeographicalAxis=endp:InternationalMember
PeriodValueUnitFiledEvidence
2013-01-01 – 2013-12-31177172000 USD20140303Open filing evidence
2013-07-01 – 2013-09-3035760000 USD20131105Open filing evidence
2013-01-01 – 2013-09-30126776000 USD20131105Open filing evidence
2013-04-01 – 2013-06-3046731000 USD20130806Open filing evidence
2013-01-01 – 2013-06-3091016000 USD20130806Open filing evidence
2013-01-01 – 2013-03-3144285000 USD20130507Open filing evidence
2012-01-01 – 2012-12-31174400000 USD20140303Open filing evidence
2012-07-01 – 2012-09-3037824000 USD20131105Open filing evidence
2012-01-01 – 2012-09-30125216000 USD20131105Open filing evidence
2012-04-01 – 2012-06-3044196000 USD20130806Open filing evidence
2012-01-01 – 2012-06-3087392000 USD20130806Open filing evidence
2012-01-01 – 2012-03-3143196000 USD20130507Open filing evidence
2011-01-01 – 2011-12-3197837000 USD20140303Open filing evidence
2011-07-01 – 2011-09-3039712000 USD20121105Open filing evidence
2011-01-01 – 2011-09-3050953000 USD20121105Open filing evidence
2011-04-01 – 2011-06-3011241000 USD20120807Open filing evidence
2011-01-01 – 2011-06-3011241000 USD20120807Open filing evidence
2010-01-01 – 2010-12-310 USD20130301Open filing evidence

Branded Pharmaceuticals

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=endp:BrandedPharmaceuticalsMember
PeriodValueUnitFiledEvidence
2012-01-01 – 2012-03-31363574000 Unit1220120501Open filing evidence
2011-01-01 – 2011-12-311657767000 Unit1220120229Open filing evidence
2011-07-01 – 2011-09-30425511000 Unit1220111031Open filing evidence
2011-01-01 – 2011-09-301199292000 Unit1220111031Open filing evidence
2011-04-01 – 2011-06-30398267000 Unit1220110831Open filing evidence
2011-01-01 – 2011-06-30773781000 Unit1220110831Open filing evidence
2011-01-01 – 2011-03-31375514000 Unit1220120501Open filing evidence
2010-01-01 – 2010-12-311467572000 Unit1220120229Open filing evidence
2010-07-01 – 2010-09-30364986000 Unit1220111031Open filing evidence
2010-01-01 – 2010-09-301072362000 Unit1220111031Open filing evidence
2010-04-01 – 2010-06-30368840000 Unit1220110831Open filing evidence
2010-01-01 – 2010-06-30707376000 Unit1220110831Open filing evidence
2009-01-01 – 2009-12-311336110000 Unit1220120229Open filing evidence

Devices And Services

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=endp:DevicesAndServicesMember
PeriodValueUnitFiledEvidence
2011-07-01 – 2011-09-30185592000 Unit1220111031Open filing evidence
2011-01-01 – 2011-09-30311992000 Unit1220111031Open filing evidence
2011-04-01 – 2011-06-3076297000 Unit1220110831Open filing evidence
2011-01-01 – 2011-06-30126400000 Unit1220110831Open filing evidence
2010-07-01 – 2010-09-3051686000 Unit1220111031Open filing evidence
2010-01-01 – 2010-09-3051686000 Unit1220111031Open filing evidence

Devices

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=endp:DevicesMember
PeriodValueUnitFiledEvidence
2012-01-01 – 2012-03-31130166000 Unit1220120501Open filing evidence
2011-01-01 – 2011-12-31300299000 Unit1220120229Open filing evidence

Devices · US

Statement Business Segments · Statement Geographical

Source dimensions us-gaap:StatementBusinessSegmentsAxis=endp:DevicesMember;us-gaap:StatementGeographicalAxis=country:US
PeriodValueUnitFiledEvidence
2012-01-01 – 2012-03-3186970000 Unit1220120501Open filing evidence
2011-01-01 – 2011-12-31202462000 Unit1220120229Open filing evidence

Devices · International

Statement Business Segments · Statement Geographical

Source dimensions us-gaap:StatementBusinessSegmentsAxis=endp:DevicesMember;us-gaap:StatementGeographicalAxis=endp:InternationalMember
PeriodValueUnitFiledEvidence
2012-01-01 – 2012-03-3143196000 Unit1220120501Open filing evidence
2011-01-01 – 2011-12-3197837000 Unit1220120229Open filing evidence

Endo Pharmaceuticals

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=endp:EndoPharmaceuticalsMember
PeriodValueUnitFiledEvidence
2013-01-01 – 2013-12-311394015000 USD20140303Open filing evidence
2013-07-01 – 2013-09-30366136000 USD20131105Open filing evidence
2013-01-01 – 2013-09-301139372000 USD20131105Open filing evidence
2013-04-01 – 2013-06-30415647000 USD20130806Open filing evidence
2013-01-01 – 2013-06-30773236000 USD20130806Open filing evidence
2013-01-01 – 2013-03-31357589000 USD20130507Open filing evidence
2012-01-01 – 2012-12-311677984000 USD20140303Open filing evidence
2012-07-01 – 2012-09-30416645000 USD20131105Open filing evidence
2012-01-01 – 2012-09-301223005000 USD20131105Open filing evidence
2012-04-01 – 2012-06-30442786000 USD20130806Open filing evidence
2012-01-01 – 2012-06-30806360000 USD20130806Open filing evidence
2012-01-01 – 2012-03-31363574000 USD20130507Open filing evidence
2011-01-01 – 2011-12-311657767000 USD20140303Open filing evidence
2011-07-01 – 2011-09-30425511000 USD20121105Open filing evidence
2011-01-01 – 2011-09-301199292000 USD20121105Open filing evidence
2011-04-01 – 2011-06-30398267000 USD20120807Open filing evidence
2011-01-01 – 2011-06-30773781000 USD20120807Open filing evidence
2010-01-01 – 2010-12-311467572000 USD20130301Open filing evidence

Generics

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=endp:GenericsMember
PeriodValueUnitFiledEvidence
2012-01-01 – 2012-03-31145345000 Unit1220120501Open filing evidence
2011-01-01 – 2011-12-31566854000 Unit1220120229Open filing evidence
2011-07-01 – 2011-09-30147975000 Unit1220111031Open filing evidence
2011-01-01 – 2011-09-30415431000 Unit1220111031Open filing evidence
2011-04-01 – 2011-06-30133047000 Unit1220110831Open filing evidence
2011-01-01 – 2011-06-30267456000 Unit1220110831Open filing evidence
2011-01-01 – 2011-03-31134409000 Unit1220120501Open filing evidence
2010-01-01 – 2010-12-31146513000 Unit1220120229Open filing evidence
2010-07-01 – 2010-09-3027431000 Unit1220111031Open filing evidence
2010-01-01 – 2010-09-3080991000 Unit1220111031Open filing evidence
2010-04-01 – 2010-06-3027684000 Unit1220110831Open filing evidence
2010-01-01 – 2010-06-3053560000 Unit1220110831Open filing evidence
2009-01-01 – 2009-12-31124731000 Unit1220120229Open filing evidence

Healthtronics

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=endp:HealthtronicsMember
PeriodValueUnitFiledEvidence
2013-07-01 – 2013-09-3053635000 USD20131105Open filing evidence
2013-01-01 – 2013-09-30158021000 USD20131105Open filing evidence
2013-04-01 – 2013-06-3054361000 USD20130806Open filing evidence
2013-01-01 – 2013-06-30104386000 USD20130806Open filing evidence
2013-01-01 – 2013-03-3150025000 USD20130507Open filing evidence
2012-01-01 – 2012-12-31211627000 USD20130301Open filing evidence
2012-07-01 – 2012-09-3054463000 USD20131105Open filing evidence
2012-01-01 – 2012-09-30160387000 USD20131105Open filing evidence
2012-04-01 – 2012-06-3054376000 USD20130806Open filing evidence
2012-01-01 – 2012-06-30105924000 USD20130806Open filing evidence
2012-01-01 – 2012-03-3151548000 USD20130507Open filing evidence
2011-01-01 – 2011-12-31205201000 USD20130301Open filing evidence
2011-07-01 – 2011-09-3054073000 USD20121105Open filing evidence
2011-01-01 – 2011-09-30153661000 USD20121105Open filing evidence
2011-04-01 – 2011-06-3049485000 USD20120807Open filing evidence
2011-01-01 – 2011-06-3099588000 USD20120807Open filing evidence
2010-01-01 – 2010-12-31102144000 USD20130301Open filing evidence

Qualitest

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=endp:QualitestMember
PeriodValueUnitFiledEvidence
2013-01-01 – 2013-12-31730666000 USD20140303Open filing evidence
2013-07-01 – 2013-09-30183939000 USD20131105Open filing evidence
2013-01-01 – 2013-09-30532722000 USD20131105Open filing evidence
2013-04-01 – 2013-06-30170530000 USD20130806Open filing evidence
2013-01-01 – 2013-06-30348783000 USD20130806Open filing evidence
2013-01-01 – 2013-03-31178253000 USD20130507Open filing evidence
2012-01-01 – 2012-12-31633265000 USD20140303Open filing evidence
2012-07-01 – 2012-09-30166070000 USD20131105Open filing evidence
2012-01-01 – 2012-09-30471310000 USD20131105Open filing evidence
2012-04-01 – 2012-06-30159895000 USD20130806Open filing evidence
2012-01-01 – 2012-06-30305240000 USD20130806Open filing evidence
2012-01-01 – 2012-03-31145345000 USD20130507Open filing evidence
2011-01-01 – 2011-12-31566854000 USD20140303Open filing evidence
2011-07-01 – 2011-09-30147975000 USD20121105Open filing evidence
2011-01-01 – 2011-09-30415431000 USD20121105Open filing evidence
2011-04-01 – 2011-06-30133047000 USD20120807Open filing evidence
2011-01-01 – 2011-06-30267456000 USD20120807Open filing evidence
2010-01-01 – 2010-12-31146513000 USD20130301Open filing evidence

Services

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=endp:ServicesMember
PeriodValueUnitFiledEvidence
2012-01-01 – 2012-03-3151548000 Unit1220120501Open filing evidence
2011-01-01 – 2011-12-31205201000 Unit1220120229Open filing evidence
2011-01-01 – 2011-03-3150103000 Unit1220120501Open filing evidence
2010-01-01 – 2010-12-31102144000 Unit1220120229Open filing evidence